|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||20.22 mL||101.11 mL||202.22 mL|
|0.5 mM||4.04 mL||20.22 mL||40.44 mL|
|1 mM||2.02 mL||10.11 mL||20.22 mL|
|5 mM||0.4 mL||2.02 mL||4.04 mL|
*The above data is based on the productmolecular weight 494.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
|Synonyms||R-1626,R 1626, R1626, Ro 4588161|
VX-222 is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus…
BMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection.
Boceprevir is a protease inhibitor used as a treatment for hepatitis C genotype 1.
Telaprevir (VX-950) is known as protease inhibitors that inhibits the hepatitis C virus NS3.4A serine protease.
Ciluprevir is a specific and potent peptidomimetic inhibitor of the HCV NS3 protease.